International Clinical Trials Day 2026, a year in review: Access to Trials
CLINICAL TRIALS IN REGIONAL, RURAL AND REMOTE AUSTRALIA
With
Amanda Koegelenberg,
CEO, Novatrials
INTERNATIONAL CLINICAL TRIALS DAY SERIES SEGMENT
Filmed in Newcastle, NSW | May 2026
To mark International Clinical Trials Day 2026, Australian Health Journal commences a 4 part special series leading up to 20th May with interviews captured across Australia. Through conversations with leading researchers, clinicians and trial organisations, the series highlights achievements in the year that was for clinical trials. The first segment is an example of how in-person clinical trial access has improved for regional, rural and remote communities.
Novatrials is helping transform access to clinical trials for people living in regional, rural and remote communities across the Hunter New England region and beyond. Based in Newcastle, New South Wales, the organisation was founded with a vision to bring innovative medical treatments closer to communities that have traditionally faced significant travel barriers to access state-of-the-art healthcare.
With the first purpose-built Phase 1 clinical trial facility outside of an Australian capital city, Novatrials is expanding opportunities for participants across Newcastle, the wider Hunter region and regional New South Wales to take part in world-class research closer to home. By conducting Phase 1 through to Phase 4 studies across a range of therapeutic areas, the organisation is helping bridge the gap between laboratory innovation and real-world patient care.
According to CEO Amanda Koegelenberg, the investment in the facility illustrates Novatrials’ commitment to ensuring people in regional and remote areas no longer need to travel vast distances to participate in clinical trials, while also bringing more research investment, innovation and healthcare opportunities into the Hunter New England region.
The segment highlights how Novatrials is working collaboratively with partners including the University of Newcastle, Hunter Medical Research Institute and Hunter New England Local Health District to strengthen the region’s research ecosystem and improve access to emerging treatments for local communities.
Source: Adapted from transcript using AI
You Might also like
-
Using human skin hair follicles to treat Alzheimer’s disease
Professor Michael Valenzuela is a science opinion leader, innovator and creative thinker with a career-long commitment to the prevention and treatment of dementia.
Following that he completed graduate medicine and medical training at the Prince of Wales Hospital. In 2012, he established the Regenerative Neuroscience Group at the University of Sydney, and in 2017 became the university’s first Professor of Regenerative Medicine.
Professor Valenzuela’s group discovered a new cell type with potential for regenerative medicine, a rare neural precursor cell found deep within the human hair follicle. He is the main inventor on several related patents and is the Founder and Chief Scientific Officer of Skin2Neuron – a biotech company developing the first neurorestorative cell therapy for Alzheimer’s disease based on this work.
-
Digital Health Funding and Operating Models Government New Content Op-Ed Regulatory and Reimbursement
Funding roadblocks creating digital health inequity
Helen Souris, CEO and Executive Director of Cardihab and Chair of the Digital Health Advisory Group at the Medical Technology Association of Australia (MTAA), highlights the significant gap in cardiac rehabilitation access across Australia. Despite the proven benefits of cardiac rehabilitation in improving survival, quality of life, and reducing hospital admissions, around 80% of eligible patients do not receive this care, with access rates even lower in regional and rural communities.
-
Retaining a clinical perspective in macro level changes
Dr Shona Sundaraj BAppSc (Phty), MBBS, FRACGP, MBA is Group Medical Director at Medibank, bringing over two decades of clinical and systems experience to strategy, research and stakeholder engagement. She leads the Medibank Better Health Research Hub and Chairs the Health Research Governance Committee, guiding stakeholder engagement, competitive grant rounds and partnerships with universities, translational research centres and peak bodies to support evidence based improvement in care.